McGill J I, Collins P, Cantell K, Jones B R, Finter N B
J Infect Dis. 1976 Jun;133 Suppl:A13-7. doi: 10.1093/infdis/133.supplement_2.a13.
The 50% infectious dose of a preparation of herpes simplex virus was measured in eyes of rabbits by a multiple corneal inoculation method. One hour after inoculation of virus, one eye was treated with drops of human leukocyte interferon, and the other was treated with saline or with a different dose of interferon. Results from groups of three to four rabbits were combined for analysis. Treatment reduced the 50% infectious dose of virus in proportion to the concentration of interferon applied (within the range of 6.5 X 10(4)-1.3 X 10(6) units/ml) and not according to the total number of units instilled. Different treatment schedules were tried. Two applications of interferon each day were as effective as eight applications at intervals of 15 min or 1 hr. One application produced near-maximal antiviral effects for 18-24 hr. Thus, in human herpetic keratitis, a single daily application of the most concentrated available preparation of human interferon might be the most efficient schedule of treatment.
采用多次角膜接种法,在兔眼内测定单纯疱疹病毒制剂的半数感染剂量。接种病毒1小时后,一只眼用人类白细胞干扰素滴眼液治疗,另一只眼用生理盐水或不同剂量的干扰素治疗。将三到四只兔子一组的结果合并进行分析。治疗可使病毒的半数感染剂量按所应用干扰素的浓度成比例降低(在6.5×10⁴ - 1.3×10⁶单位/毫升范围内),而非按滴入的单位总数降低。尝试了不同的治疗方案。每天两次应用干扰素与每隔15分钟或1小时应用八次一样有效。一次应用可产生持续18 - 24小时的接近最大的抗病毒效果。因此,在人类疱疹性角膜炎中,每天单次应用现有最浓缩的人类干扰素制剂可能是最有效的治疗方案。